4595 MIZUHO MEDY CO.,LTD. - Financial Results

About Information Provided on This Site

The information provided on our website 'Kabutan.com' is not intended to constitute investment solicitation or investment advisory services.
All investment decisions should be made at your own discretion and judgment.
The data on our website is provided by Tokyo Stock Exchange, Osaka Exchange, Nagoya Securities Exchange, JPX Market Innovation & Research, Japannext, and other sources.
Copyright of the Nikkei Stock Average belongs to Nikkei Inc. Stock price charts displayed on Kabutan.com are provided solely for the purpose of reviewing historical price movements of the securities.
These charts neither suggest nor guarantee future price movements of the securities and do not constitute recommendations to buy or sell.
In our financial results coverage, the term 'Surprise Results' identifies securities that demonstrate a significant degree of surprise in their earnings announcements.
This significance is quantitatively assessed based on multiple factors, including: the nature of the announcement (full-year or quarterly results); types of revisions (earnings or dividend forecasts); and numerical analysis comparing the announced results with both the company's previous forecasts and historical performance.
The 'Surprise Ranking' presents these results in order of their calculated surprise factor. Please note that neither these results nor rankings are intended to suggest or guarantee future performance of the listed securities, nor should they be construed as recommendations to buy or sell.

4595

TSE Standard

MIZUHO MEDY CO.,LTD.

1,479

JPY

(+0.14%)

Dec 23, 3:23 pm JST

9.43

USD

Dec 23, 1:00 am EST

Result

PTS

outside of trading hours

1,478.2

Dec 23, 3:24 pm JST

Summary Chart Historical News Financial Result

Current Period Guidance

Annual

Result

Guidance History

Growth Rate

Profitability

Fiscal Year	Revenue	Operating Profit	Ordinary Profit	Net Profit	Adj. EPS	Adj. Dividend	Announce	Accounting Standards
Dec, 2020	4,205	416	415	306	16.1	5	Feb 10, 2021	J-GAAP
Dec, 2021	13,137	6,698	6,700	4,816	252.9	77.50	Feb 10, 2022	J-GAAP
Dec, 2022	17,581	11,104	11,070	7,838	411.5	125	Feb 10, 2023	J-GAAP
Dec, 2023	10,989	5,151	5,292	3,774	198.1	100	Feb 9, 2024	J-GAAP
Dec, 2024 Guidance	10,430	4,162	4,169	3,016	158.3	80	Feb 9, 2024	J-GAAP
YoY	-5.1%	-19.2%	-21.2%	-20.1%	-20.1%

Revision Direction	Revision Date	Revenue	Operating Profit	Ordinary Profit	Net Profit	Revised Dividend	Accounting Standards
Dec, 2019	Feb 12, 2019	7,779	1,422	1,408	1,035	16.5	J-GAAP
	May 13, 2019	7,072	1,321	1,306	965	15.5	J-GAAP
Results	Feb 12, 2020	6,427	1,111	1,111	874	14.5	J-GAAP
Dec, 2020	Feb 12, 2020	Available in future release
	Mar 19, 2020
	Aug 11, 2020
	Nov 9, 2020
Results	Feb 10, 2021
Dec, 2021	Feb 10, 2021
	May 10, 2021
	Aug 10, 2021
	Nov 8, 2021
Results	Feb 10, 2022
Dec, 2022	Feb 10, 2022
	May 9, 2022
	Aug 10, 2022
	Nov 11, 2022
Results	Feb 10, 2023
Dec, 2023	Feb 10, 2023
	Aug 10, 2023
	Nov 10, 2023
Results	Feb 9, 2024
Dec, 2024	Feb 9, 2024	10,430	4,162	4,169	3,016	80*	J-GAAP

Fiscal Year	Revenue	YoY	Operating Profit	YoY	Ordinary Profit	YoY	Adj. EPS	YoY
Dec, 2010	2,325	－	Available in future release
Dec, 2011	2,869	+23.4
Dec, 2012	3,183	+10.9
Dec, 2013	3,248	+2.0
Dec, 2014	3,986	+22.7
Dec, 2015	4,082	+2.4
Dec, 2016	4,961	+21.5
Dec, 2017	5,624	+13.4
Dec, 2018	6,423	+14.2
Dec, 2019	6,427	+0.1
Dec, 2020	4,205	-34.6
Dec, 2021	13,137	+212.4
Dec, 2022	17,581	+33.8
Dec, 2023	10,989	-37.5
Dec, 2024 Guidance	10,430	-5.1	4,162	-19.2	4,169	-21.2	158.3	-20.1

Fiscal Year	Revenue	Operating Profit	Operating Profit Margin	ROE	ROA	Total Asset Turnover Ratio	Adj. EPS
Dec, 2022	17,581	11,104	63.2	70.26	50.09	1.12	411.5
Dec, 2023	10,989	5,151	46.9	25.20	19.84	0.58	198.1
Dec, 2024 Guidance	10,430	4,162	39.9	18.70	15.81	0.55	158.3

All-Time High

	Revenue	Operating Profit	Ordinary Profit	Net Profit	Adj. EPS
Record	17,581	11,104	11,070	7,838	411.5
Fiscal Year	Dec, 2022	Dec, 2022	Dec, 2022	Dec, 2022	Dec, 2022

Second Half

Fiscal Year	Revenue	Operating Profit	Ordinary Profit	Net Profit	Adj. EPS	Adj. Dividend	Announce	Accounting Standards
Jul - Dec, 2021	6,784	3,574	3,572	2,520	132.3	52.50	Feb 10, 2022	J-GAAP
Jul - Dec, 2022	10,268	6,529	6,490	4,635	243.3	95	Feb 10, 2023	J-GAAP
Jul - Dec, 2023	6,414	3,248	3,239	2,313	121.4	70	Feb 9, 2024	J-GAAP
Jul - Dec, 2024 Guidance	5,762	2,319	2,088	1,527	80.2	40	Aug 9, 2024	J-GAAP
YoY	-10.2%	-28.6%	-35.5%	-34.0%	-34.0%

Cash Flow

Annual

Fiscal Year	Operating Profit	Fee Cash Flow	Operating Cash Flow	Investing Cash Flow	Financial Cash Flow	Cash & Equivalents	Cash Ratio	Accounting Standards
Dec, 2021	6,698	5,437	5,596	-159	-1,164	4,326	35.48	J-GAAP
Dec, 2022	11,104	4,619	6,172	-1,553	-1,570	7,375	38.61	J-GAAP
Dec, 2023	5,151	3,721	3,991	-270	-2,381	8,716	46.00	J-GAAP

Actual Performance and Financial Trends

Accumulated Results 3rd Quarter

Fiscal Year	Revenue	Operating Profit	Ordinary Profit	Net Profit	Adj. EPS	Progress Rate vs. First Half	Announce	Accounting Standards
Jan - Sep, 2022	13,281	8,696	8,773	6,132	321.9	79.3	Nov 11, 2022	J-GAAP
Jan - Sep, 2023	7,990	3,789	3,995	2,827	148.4	75.5	Nov 10, 2023	J-GAAP
Jan - Sep, 2024	7,989	3,481	3,558	2,550	133.9	85.3	Nov 8, 2024	J-GAAP
YoY	0.0%	-8.1%	-10.9%	-9.8%	-9.8%

Quarterly Results

Result

Growth Rate

Fiscal Year	Revenue	Operating Profit	Ordinary Profit	Net Profit	Adj. EPS	Operating Profit Margin	Announce	Accounting Standards
Oct - Dec, 2022	4,300	2,408	2,297	1,706	89.6	56.0	Feb 10, 2023	J-GAAP
Jan - Mar, 2023	2,391	1,027	1,050	746	39.2	43.0	May 12, 2023	J-GAAP
Apr - Jun, 2023	2,184	876	1,003	715	37.6	40.1	Aug 10, 2023	J-GAAP
Jul - Sep, 2023	3,415	1,886	1,942	1,366	71.7	55.2	Nov 10, 2023	J-GAAP
Oct - Dec, 2023	2,999	1,362	1,297	947	49.7	45.4	Feb 9, 2024	J-GAAP
Jan - Mar, 2024	2,742	1,252	1,372	970	51.0	45.7	May 10, 2024	J-GAAP
Apr - Jun, 2024	1,926	591	709	519	27.3	30.7	Aug 9, 2024	J-GAAP
Jul - Sep, 2024	3,321	1,638	1,477	1,061	55.7	49.3	Nov 8, 2024	J-GAAP
YoY	-2.8%	-13.1%	-23.9%	-22.3%	-22.3%

Fiscal Year	Revenue	YoY	Operating Profit	YoY	Ordinary Profit	YoY	Adj. EPS	YoY
Oct - Dec, 2019	2,298	+6.7	Available in future release
Jan - Mar, 2020	1,052	-42.1
Apr - Jun, 2020	611	-40.7
Jul - Sep, 2020	828	-35.5
Oct - Dec, 2020	1,714	-25.4
Jan - Mar, 2021	2,443	+132.2
Apr - Jun, 2021	3,910	+539.9
Jul - Sep, 2021	4,223	+410.0
Oct - Dec, 2021	2,561	+49.4
Jan - Mar, 2022	4,188	+71.4
Apr - Jun, 2022	3,125	-20.1
Jul - Sep, 2022	5,968	+41.3
Oct - Dec, 2022	4,300	+67.9
Jan - Mar, 2023	2,391	-42.9
Apr - Jun, 2023	2,184	-30.1
Jul - Sep, 2023	3,415	-42.8
Oct - Dec, 2023	2,999	-30.3
Jan - Mar, 2024	2,742	+14.7
Apr - Jun, 2024	1,926	-11.8
Jul - Sep, 2024	3,321	-2.8	1,638	-13.1	1,477	-23.9	55.7	-22.3

All-Time High Quarterly Results

	Revenue	Operating Profit	Ordinary Profit	Net Profit	Adj. EPS
Record	5,968	4,121	4,193	2,929	153.8
Fiscal Year	Sep, 2022	Sep, 2022	Sep, 2022	Sep, 2022	Sep, 2022

Key Balance Sheet Figures

Fiscal Year	BPS	Equity Ratio	Total Asset	Equity	Retained Earnings	Interest-Bearing Debt Ratio	Announce	Accounting Standards
Dec, 2021	842.95	65.8	12,192	8,028	7,291	ー	Feb 10, 2022	J-GAAP
Dec, 2022	1,499.58	74.8	19,102	14,282	13,545	ー	Feb 10, 2023	J-GAAP
Dec, 2023	1,645.86	82.7	18,948	15,675	14,938	ー	Feb 9, 2024	J-GAAP
Jan - Sep, 2024	ー	84.6	19,074	16,131	15,393	ー	Nov 8, 2024	J-GAAP

MIZUHO MEDY CO.,LTD.(4595) Financial Results